Tracking the KRYS option chain helps you see every strike and expiry on Krystal Biotech Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Krystal Biotech Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of KRYS options activity at a glance. Use our scanner to monitor the KRYS option chain in real time and filter for the KRYS options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For KRYS stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the KRYS option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where KRYS stock options are being actively traded and where they are not.
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing KB105 that is in Phase I/II clinical study for treating patients with deficient autosomal recessive congenital ichthyosis; KB301, which is in Phase I/II clinical stage for treating wrinkles and other presentations of aged or damaged skin; KB407 that is in preclinical stage for cystic fibrosis; and KB104, which is in preclinical stage for netherton syndrome.
Its discovery stage product candidates include KB5xx for treating chronic skin diseases, KB3xx to treat aesthetic skin conditions, and KB3xx product. Krystal Biotech, Inc. was founded in 2015 and is headquartered in Pittsburgh, Pennsylvania.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Krystal Biotech Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen KRYS options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of KRYS stock options — let the full option chain come to you, pre-filtered and ready to trade.
